HV

Henrique Veiga-Fernandes

Champalimaud Research Director at Champalimaud Foundation

Henrique Veiga-Fernandes has a diverse work experience in various scientific and research roles. Henrique started their career in 2002 as a post-doctoral fellow at Hôpital Necker-Enfants Malades and later worked as a post-doctoral fellow and senior investigator scientist at NIMR. In 2009, they became a group leader at the Instituto de Medicina Molecular, where they also served on the board of directors. Henrique then went on to establish two scientific startups, StemCell2MAX in 2015 and LiMM Therapeutics in 2017, where they held the role of scientific founder. In 2016, they joined the Champalimaud Foundation as a senior group leader and later became the Champalimaud Research Director in 2019. Henrique also worked as an associate professor at Universidade de Lisboa in 2016. In 2021, they joined Science Magazine as a member of the Board of Reviewing Editors. Additionally, they served as a member of The Portuguese National Science, Technology and Innovation Council for the Portuguese Republic - XXII Government from 2021 to 2022.

Henrique Veiga-Fernandes has an impressive education history in the field of immunology. Henrique started their academic journey in 1990 at the University of Lisbon, where they pursued a degree in Veterinary Medicine until 1996. During this time, they gained foundational knowledge in the field.

In 1993-1994, Veiga-Fernandes expanded their educational horizon by studying Veterinary Medicine at Università degli Studi di Milano. This experience likely provided him with international exposure and a broader perspective in their chosen field.

Following their undergraduate studies, Veiga-Fernandes enrolled in the GABBA PhD program at Universidade do Porto in 1996-1997. Although the specific field of study is not mentioned, it can be inferred that it was related to their previous studies in Veterinary Medicine.

Veiga-Fernandes continued to advance their academic pursuits and completed a PhD in Immunology from Université Paris Cité, specializing in Immunology, from 1998 to 2002. This signifies their commitment and expertise in this particular field.

Overall, Henrique Veiga-Fernandes has a strong education background in Veterinary Medicine, with a specialization in Immunology through their PhD studies.

Links

Previous companies

LiMM Therapeutics logo

Timeline

  • Champalimaud Research Director

    November, 2019 - present

  • Senior Group Leader

    June, 2016

A panel showing how The Org can help with contacting the right person.